Industries are using AI, Digital PLM and Digital Thread, resulting in a transparent adoption that helps satisfy changing ...

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...

From diving into the ever-evolving landscape of AI in drug development to opening up the conversation to discuss regulatory hurdles and how the industry will overcome them, the Summit has been ...

As healthcare evolves at a remarkable pace, innovation in pharmaceuticals has become more than a matter of science but rather a matter of public impact. Few scientists embody this convergence better ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial ...

Strongrevenueperformance,includingapproximately$1.9millionmilestoneandlicenserevenuerecognizedin2024Up to $7.5 million in grants awarded from ...

March 2025 - Cingulate released safety data from two Phase 3 pediatric and adolescent studies - a fixed dose study and a dose ...

Continuous Optimization of Product Structure and Capacity Release from Fundraising Projects, 2024 Net Profit up 13.94% YoY The 2024 performance express report released by Dongfang Tantalum on the ...

Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $ ...